Harvard Bioscience, reporting a small decline in second-quarter revenues, said it would exploit its database of more than 150,000 academics in an effort to increase sales.

The firm also disclosed that it has engaged investment banking firm Thomas Weisel Partners to help it find a buyer for the capital equipment segment, which includes the struggling Genomic Solutions business. The company said it would use proceeds from the sale to pay down a $15.2 million debt facility and finance tuck-in acquisitions for the apparatus business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.